|
UBE3C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.826000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.362160E-01 |
| Normal-vs-Stage2 |
3.360000E-01 |
| Normal-vs-Stage3 |
1.742460E-02 |
| Normal-vs-Stage4 |
1.000430E-01 |
| Stage1-vs-Stage2 |
9.827000E-01 |
| Stage1-vs-Stage3 |
1.429820E-01 |
| Stage1-vs-Stage4 |
5.416800E-01 |
| Stage2-vs-Stage3 |
3.686800E-01 |
| Stage2-vs-Stage4 |
6.640000E-01 |
| Stage3-vs-Stage4 |
6.436600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.237700E-02 |
| Normal-vs-AfricanAmerican |
8.568000E-01 |
| Normal-vs-Asian |
2.049600E-01 |
| Caucasian-vs-AfricanAmerican |
3.798000E-01 |
| Caucasian-vs-Asian |
9.730600E-01 |
| AfricanAmerican-vs-Asian |
4.386400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.158100E-02 |
| Normal-vs-Female |
1.139450E-01 |
| Male-vs-Female |
1.679800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.306400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.332050E-02 |
| Normal-vs-Age(61-80Yrs) |
4.529700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.178200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.486200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.568180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.236200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.702800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.112200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.622400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.847400E-01 |
| Classical-VS-Follicular |
1.298200E-02 |
| Classical-VS-Other |
8.112400E-02 |
| Classical-VS-Normal |
3.586200E-01 |
| Tall-VS-Follicular |
4.354000E-01 |
| Tall-VS-Other |
2.244400E-01 |
| Tall-VS-Normal |
2.274600E-01 |
| Follicular-VS-Other |
4.157200E-01 |
| Follicular-VS-Normal |
9.395600E-03 |
| Other-VS-Normal |
1.929810E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.253700E-02 |
| Normal-vs-N1 |
1.681750E-02 |
| N0-vs-N1 |
4.203800E-01 |
|
|
